Katelyn N Seale,Katherine H R Tkaczuk
Katelyn N Seale
Breast cancer management has progressed immensely over the decades, but the disease is still a major source of morbidity and mortality worldwide. Even with enhanced imaging detection and tissue biopsy capabilities, disease can progress on a...
Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer [0.03%]
早期乳腺癌内分泌治疗女性患者的电子队列中的生活质量
Louise Benoit,Carine Cambra,Roman Rouzier et al.
Louise Benoit et al.
Objective: The objective of our study was to analyze quality of life (QOL) in an e-cohort of patients treated for breast cancer (BC) by endocrine therapy (ET), by means of validated quality of life questionnaires. ...
A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer [0.03%]
早期，激素受体阳性，HER2阴性乳腺癌辅助治疗中比美伐度齐，甲氨蝶呤和氟尿嘧啶（CMF）与多西他赛和比美伐度齐（TC）的回顾性分析
Lindsey Jung,Abby Miske,Amy Indorf et al.
Lindsey Jung et al.
Background: Anthracycline and taxane-based doublets have largely replaced cyclophosphamide, methotrexate, and fluorouracil (CMF) as preferred regimens in the adjuvant treatment of breast cancer. Metronomic CMF is associat...
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence [0.03%]
年轻女性原发性转移性乳腺癌：当前证据回顾
Benedetta Conte,Davide Soldato,Maria Grazia Razeti et al.
Benedetta Conte et al.
Women with metastatic breast cancer remains a heterogeneous group of patients with different prognostic outcomes and therapeutic needs. Young women with de novo metastatic breast cancer (dnMBC) represent a peculiar population with respect t...
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review [0.03%]
到了更新关于他莫昔芬和抗抑郁药同时使用的基于证据的指南建议的时候了吗？系统评价
Michelle Bradbury,Brian Hutton,Ana-Alicia Beltran-Bless et al.
Michelle Bradbury et al.
Concerns around pharmacological interaction between tamoxifen and antidepressants have resulted in evidence-base guidelines that recommend avoidance or caution with concurrent use. It remains unclear however whether this interaction is clin...
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors [0.03%]
既往接受过CDK4/6抑制剂治疗的转移性激素受体阳性乳腺癌患者使用依维莫司和依西美坦治疗的实际结果研究
Hanjie Mo,Catherine E Renna,Halle C F Moore et al.
Hanjie Mo et al.
Purpose: Everolimus with exemestane (EVE+EXE) was FDA-approved to treat metastatic hormone receptor-positive breast cancer (mHRBC) based on BOLERO-2. However, none of those patients received prior CDK4/6 inhibitors. The p...
A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China [0.03%]
中国179例同期和异时性双侧乳腺癌的临床病理特点及结局的回顾研究
Huiqing Jia,Yan Zheng,Ping Wang et al.
Huiqing Jia et al.
Objective: To investigate the clinicopathologic characteristics and outcome of bilateral breast cancer (BBC) in the Chinese population. Methods: ...
Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study [0.03%]
21基因复发评分检测对激素受体阳性、HER2阴性、1-3枚淋巴结转移的乳腺癌患者治疗的影响：一项前瞻性的临床应用研究
Nathalie LeVasseur,Julia Sun,David Fenton et al.
Nathalie LeVasseur et al.
Purpose: The use of the 21-gene Recurrence Score (RS) assay is emerging in node-positive estrogen receptor (ER)+ HER2-negative breast cancer (BC), particularly as initial data from the RxPONDER trial are now available. We...
Multicenter Study
Clinical breast cancer. 2022 Jan;22(1):e74-e79. DOI:10.1016/j.clbc.2021.09.004 2022
Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study [0.03%]
局部晚期乳腺癌乳腺/胸壁和区域淋巴结的低分割放射治疗（HFRT）：回顾性单机构研究中的毒性特征和生存结果
Sara De Matteis,Giuseppe Facondo,Maurizio Valeriani et al.
Sara De Matteis et al.
Aim: To evaluate the efficacy and safety of hypofractionated radiation therapy (HFRT) of the breast/chest wall and regional nodes in patients with locally advanced breast cancer and positive lymph nodes. ...